Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about DEA

Recent news which mentions DEA

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
Tickers AKYA ALKS AVDX BILI
Tags Analyst Ratings BSFC CLH
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
Tickers CSA DEA
Tags DEA News Market News
From Benzinga
3 Top Dividend Stocks to Buy and Hold in 2023
Tickers ABBV BEP BEPC DEA
Tags Market News BEPC ABBV
From Motley Fool
3 High-Yield Dividend Stocks That Could Be Passive-Income Machines
Tickers DEA DVN MPW
Tags Market News DEA DVN
From Motley Fool
DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023
Tickers DEA
Tags Cannabis Research DEA Marijuana Moment
From Benzinga
3 Attractive REITs With A Dividend Yield Over 6%
Tickers DEA REIT SPG UHT
Tags Alternative investments Benzinga Small Cap
From Benzinga
3 Ridiculously Cheap High-Yield Dividend Stocks
Tickers DEA DOC STAG
Tags DEA Recent Press Releases STAG
From Motley Fool
DEA's Beginnings Steeped In Racially Discriminatory Drug Laws, Here's Why
Tickers DEA
Tags Politics Benzinga Stories from the Collection
From Benzinga
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
Tickers DEA GSK JNJ
Tags Small Business George Hodgin GSK
From Benzinga
DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
Tickers DEA LFLY
Tags Sales Politics Penny Stocks
From Benzinga
DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests
Tickers DEA
Tags Markets Benzinga RTT statute
From Benzinga
Congressional Psychedelics Talks: Comments By Officials In Favor, Including Rep. Blumenauer And AOC
Tickers AOC DEA
Tags Cannabis AOC Markets
From Benzinga
What 4 Analyst Ratings Have To Say About Easterly Government Props
Tickers DEA
Tags Benzinga Analyst Ratings Market News
From Benzinga
3 High-Yield Dividend Stocks to Buy in September Without Any Hesitation
Tickers DEA EPD MPW
Tags DEA MPW Recent Press Releases
From Motley Fool
Fetterman Calls On Biden To Decriminalize Cannabis, But White House Defers To States
Tickers DEA
Tags Politics John Fetterman marijuana reform
From Benzinga
These dividend stocks can protect you as the Federal Reserve slows the economy
Tickers AIRC AKR AMT AMZN
Tags PLD OUT UMH
From MarketWatch
DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion
Tickers DEA
Tags Psychedelics Market News Emory University
From Benzinga
Good News For Maridose, DEA Grants A Cannabis Cultivation License For Research
Tickers DEA
Tags News Maridose Cannabis
From Benzinga
CNBC's Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company
Tickers AMGN DEA ITW XOM
Tags Jim Lebenthal Small Cap Benzinga
From Benzinga
Apple, IBM Are CNBC 'Fast Money' Calls Of The Day
Tickers AAPL AMGN DEA IBM
Tags AMGN General IBM
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
Tickers CYBN DEA MDD
Tags Cybin Cannabis Biotech
From Benzinga
3 Dividend Stocks to Buy Right Now Without Any Hesitation
Tickers BEP BEPC DEA MPW
Tags BEP DEA Market News
From Motley Fool
Senate Marijuana & Psychedelics Reforms: Appropriations Committee Chair Patrick Leahy Marks 12 Bills For FY 2023
Tickers DEA
Tags Markets Benzinga FDA
From Benzinga
3 High-Yield Dividend Stocks to Buy in August
Tickers DEA EPD MPW
Tags EPD Market News MPW
From Motley Fool
DEA Reports Uptick In Marijuana-Related Seizures & Arrests: Why Is This Happening? NORML Has An Idea
Tickers DEA
Tags Politics Marijuana Seizures Legal
From Benzinga
This REIT Is Essentially a Bond With Upside
Tickers DEA
Tags DEA Recent Press Releases Market News
From Motley Fool
Cannabis Reg. Update: FDA To Review CBD Again, DEA Wins In Hemp Extract Case & More
Tickers DEA
Tags Politics Malaysia policy
From Benzinga
DEA Stonewalling MMJ's MS & Huntington's Disease Clinical Trials For 3 Years
Tickers DEA
Tags DEA News MMJ BioPharma Labs
From Benzinga
Activists Protest The DEA For Psilocybin Access
Tickers DEA
Tags Market News Psychedelics Psilocybin
From Benzinga
DEA Delays Medical Marijuana Clinical Trials Yet Illicit Market Continues To Thrive
Tickers DEA
Tags FDA Benzinga Duane Boise
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.